GenapSys to Offer Twist Bioscience Library Prep, Target Enrichment Products

Feb 24, 2020

|

NEW YORK — GenapSys said on Monday that it has signed an agreement to offer Twist Bioscience's library preparation and target enrichment products to customers of its portable DNA sequencing system.

GenapSys launched its lunchbox-sized electronic sequencer, which uses microfluidic CMOS chips and has a list price of $10,000, in late 2019.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Analysis for the Long Term

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

Pricey, But Available

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Pilot Cancer Testing Program for Taiwan

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

PLOS Papers on TB Resistance, Squamous Cell Carcinoma Risk, MicroRNAs in SCC

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.

Featured White Papers

Expand Bulk Sequencing Analysis with BioLegend and Illumina

Single-cell DNA Analysis of a Novel Acute Erythroid Leukemia (AEL) CRISPR Induced Mouse Model

Analyze, Interpret and Report NGS Data Faster than Ever Before

Single-cell Sequencing 101: DNA & Multiomics for Precision Medicine

Mar

09

Featured Webinar

Implementation of Whole-Exome and Virtual Panel Testing for Rare Disease at a Children’s Hospital

The growth of next-generation sequencing (NGS) testing presents both opportunities and challenges for clinical, informatics, and laboratory teams.

Mar

11

Featured Webinar

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

In this session, the third in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified gene fusions that may or may not serve as druggable targets.

Mar

16

Featured Webinar

The Predictive Power of Poop: COVID-19 Wastewater Surveillance to Inform Public Health Decisions in Colorado

Wastewater based epidemiology (WBE) has been established as a viable, valuable, and cost-effective means to monitor infectious disease within a community.

Mar

18

Featured Webinar

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

Viruses mutate as they strive to thrive in response to selective pressures.

Menu

GenapSys to Offer Twist Bioscience Library Prep, Target Enrichment Products

To read the full story....

Breaking News

Top Five Articles on GenomeWeb Last Week: Agilent, Hologic, Bio-Techne, and More

Bio-Rad Laboratories, Roche Enter Quality Control Partnership

FDA Issues EUA for Adaptive Biotechnologies COVID-19 T-Cell Response Test

Cue Health Over-the-Counter COVID-19 Test Gets FDA Emergency Use Authorization

Fauna Bio Gets $373K NIH Grant to Study Animal Genomes for Potential Drug Targets

New Products Posted to GenomeWeb: Purigen Biosystems, Zymo Research, Qiagen, More

The Scan

Analysis for the Long Term

Pricey, But Available

Pilot Cancer Testing Program for Taiwan

PLOS Papers on TB Resistance, Squamous Cell Carcinoma Risk, MicroRNAs in SCC

Featured White Papers

Implementation of Whole-Exome and Virtual Panel Testing for Rare Disease at a Children’s Hospital

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

The Predictive Power of Poop: COVID-19 Wastewater Surveillance to Inform Public Health Decisions in Colorado

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

What's Popular?

FDA Issues EUA for Adaptive Biotechnologies COVID-19 T-Cell Response Test

At AGBT, Two Labs Share SARS-CoV-2 Genomic Surveillance Experience

Agilent Charges Into Liquid Biopsy Space with Resolution Biosciences Acquisition

Illumina Receives Medical Device Registration in Russia for NextSeq 550 Dx Sequencer, Reagents

Bio-Techne to Acquire Molecular Diagnostics Firm Asuragen for up to $320M

Sponsorships